Zobrazeno 1 - 10
of 318
pro vyhledávání: '"Roncador, M."'
Autor:
Özoğul E; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Pathology Department, Hacettepe University Faculty of Medicine, Ankara, Turkey., Montaner A; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Pol M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Frigola G; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Hospital Clínic de Barcelona, Barcelona, Spain.; University of Barcelona, Barcelona, Spain., Balagué O; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Hospital Clínic de Barcelona, Barcelona, Spain.; University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Syrykh C; Toulouse University Hospital Center, Cancer Institute University of Toulouse-Oncopole, 1 avenue Irène Joliot-Curie, 31059, Toulouse, CEDEX 9, France.; INSERM UMR1037 Cancer Research Center of Toulouse (CRCT), ERL 5294 National Center for Scientific Research (CNRS), University of Toulouse III Paul-Sabatier, Toulouse, France.; Institut Carnot Lymphome CALYM, Laboratoire d'Excellence 'TOUCAN', Toulouse, France., Bousquets-Muñoz P; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo, 33006, Oviedo, Spain., Royo R; Barcelona Supercomputer Center, Barcelona, Spain., Fontaine J; Hopital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France., Traverse-Glehen A; Hopital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France., Bühler MM; University Hospital Zurich, Zurich, Switzerland., Giudici L; Institute of Pathology, Ente Ospedaliero Cantonale (EOC), 6900, Locarno, Switzerland., Roncador M; University Hospital Zurich, Zurich, Switzerland., Zenz T; University Hospital Zurich, Zurich, Switzerland., Carras S; Grenoble Alpes University, CHU Grenoble Alpes and INSERMN UMR 1209/CNRS 5309, Institute for Advanced Biosciences, Grenoble, France., Valmary-Degano S; Grenoble Alpes University, CHU Grenoble Alpes and INSERMN UMR 1209/CNRS 5309, Institute for Advanced Biosciences, Grenoble, France., de Leval L; Lausanne University Hospital and Lausanne University, Lausanne, Switzerland., Bosch-Schips J; Hospital Universitari de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Spain., Climent F; Hospital Universitari de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Spain., Salmeron-Villalobos J; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Bashiri M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Ruiz-Gaspà S; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Costa D; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Hospital Clínic de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Beà S; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Hospital Clínic de Barcelona, Barcelona, Spain.; University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Salaverria I; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Giné E; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Hospital Clínic de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Quintanilla-Martinez L; Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany., Brousset P; Toulouse University Hospital Center, Cancer Institute University of Toulouse-Oncopole, 1 avenue Irène Joliot-Curie, 31059, Toulouse, CEDEX 9, France.; INSERM UMR1037 Cancer Research Center of Toulouse (CRCT), ERL 5294 National Center for Scientific Research (CNRS), University of Toulouse III Paul-Sabatier, Toulouse, France.; Institut Carnot Lymphome CALYM, Laboratoire d'Excellence 'TOUCAN', Toulouse, France., Raffeld M; National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Jaffe ES; National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Puente XS; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo, 33006, Oviedo, Spain., López C; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Hospital Clínic de Barcelona, Barcelona, Spain.; University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Nadeu F; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Campo E; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. ecampo@clinic.cat.; Hospital Clínic de Barcelona, Barcelona, Spain. ecampo@clinic.cat.; University of Barcelona, Barcelona, Spain. ecampo@clinic.cat.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. ecampo@clinic.cat.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2024 Sep 23; Vol. 14 (1), pp. 166. Date of Electronic Publication: 2024 Sep 23.
Autor:
Hofer KD; Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland., Bühler MM; Department of Pathology and Molecular Pathology, University Hospital Zurich, Switzerland., Roncador M; Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland., Rechsteiner M; Department of Pathology and Molecular Pathology, University Hospital Zurich, Switzerland., Maggio EM; Department of Pathology and Molecular Pathology, University Hospital Zurich, Switzerland., Tchinda J; Oncology Laboratory, University Children's Hospital Zurich, Switzerland., Schanz U; Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland., Haralambieva E; Department of Pathology and Molecular Pathology, University Hospital Zurich, Switzerland., Widmer CC; Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland.; Division of Hematology, University Hospital Basel, Switzerland.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2024 Jun; Vol. 65 (6), pp. 808-815. Date of Electronic Publication: 2024 Feb 22.
Autor:
Djerbi N; Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland., Zimmermann K; Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland., Roncador M; Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.; Department of Biosystems Science and Engineering, Eidgenössische technische Hochschule Zurich, Basel, Switzerland., Becker MO; Department of Rheumatology, University Hospital Zurich and University of Zurich, Zurich, Switzerland., Manz MG; Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland., Balabanov S; Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Publikováno v:
Blood advances [Blood Adv] 2023 Nov 28; Vol. 7 (22), pp. 6815-6818.
Autor:
Samur MK; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA., Roncador M; Zurich University Hospital, Zurich, Switzerland., Aktas Samur A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard University, Boston, MA., Fulciniti M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard University, Boston, MA., Bazarbachi AH; Department of Internal Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, New York, NY., Szalat R; Department of Hematology and Medical Oncology, Boston University Medical Center, Boston, MA., Shammas MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard University, Boston, MA., Sperling AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard University, Boston, MA., Richardson PG; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard University, Boston, MA., Magrangeas F; Center for Research in Cancerology and Immunology Nantes-Angers (CRCINA), INSERM, French National Centre for Scientific Research (CNRS), Angers University, and Nantes University, Nantes, France., Minvielle S; Center for Research in Cancerology and Immunology Nantes-Angers (CRCINA), INSERM, French National Centre for Scientific Research (CNRS), Angers University, and Nantes University, Nantes, France., Perrot A; University Cancer Center of Toulouse Institut National de la Santé, Toulouse, France., Corre J; University Cancer Center of Toulouse Institut National de la Santé, Toulouse, France., Moreau P; Center for Research in Cancerology and Immunology Nantes-Angers (CRCINA), INSERM, French National Centre for Scientific Research (CNRS), Angers University, and Nantes University, Nantes, France., Thakurta A; Bristol Myers Squibb, Summit, NJ., Parmigiani G; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA., Anderson KC; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard University, Boston, MA., Avet-Loiseau H; University Cancer Center of Toulouse Institut National de la Santé, Toulouse, France., Munshi NC; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard University, Boston, MA.; VA Boston Healthcare System, Boston, MA.
Publikováno v:
Blood [Blood] 2023 Apr 06; Vol. 141 (14), pp. 1724-1736.
Autor:
Gritti I; Functional Genomics of Cancer Unit, Division of Experimental Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milano, Italy., Basso V; Division of Immunology, Transplantation and Infectious Disease, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milano, Italy., Rinchai D; Cancer Research Department, Sidra Medicine, Doha, Qatar., Corigliano F; Functional Genomics of Cancer Unit, Division of Experimental Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milano, Italy., Pivetti S; Functional Genomics of Cancer Unit, Division of Experimental Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milano, Italy., Gaviraghi M; Functional Genomics of Cancer Unit, Division of Experimental Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milano, Italy., Rosano D; Functional Genomics of Cancer Unit, Division of Experimental Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milano, Italy., Mazza D; Experimental Imaging Center, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milano, Italy., Barozzi S; IFOM, The FIRC Institute of Molecular Oncology, Milano, Italy., Roncador M; Department of Data Sciences, Dana Farber Cancer Institute, Boston, MA, USA.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Parmigiani G; Department of Data Sciences, Dana Farber Cancer Institute, Boston, MA, USA.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Legube G; MCD, Centre de Biologie Intégrative (CBI), CNRS, University of Toulouse, Toulouse, France., Parazzoli D; IFOM, The FIRC Institute of Molecular Oncology, Milano, Italy., Cittaro D; Center for Omics Sciences @OSR (COSR), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milano, Italy., Bedognetti D; Cancer Research Department, Sidra Medicine, Doha, Qatar.; Dipartimento di Medicina Interna e Specialità Mediche, Università degli Studi di Genova, Genoa, Italy., Mondino A; Division of Immunology, Transplantation and Infectious Disease, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milano, Italy., Segalla S; Functional Genomics of Cancer Unit, Division of Experimental Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milano, Italy., Tonon G; Functional Genomics of Cancer Unit, Division of Experimental Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milano, Italy.; Center for Omics Sciences @OSR (COSR), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milano, Italy.; Università Vita-Salute San Raffaele, Milan, Italy.
Publikováno v:
The EMBO journal [EMBO J] 2022 Nov 17; Vol. 41 (22), pp. e108040. Date of Electronic Publication: 2022 Oct 10.
Autor:
Stolz S; Department of Medical Oncology and Haematology, University Hospital Zurich, Switzerland., Roncador M; Department of Medical Oncology and Haematology, University Hospital Zurich, Switzerland., Rösler W; Department of Medical Oncology and Haematology, University Hospital Zurich, Switzerland., Zenz T; Department of Medical Oncology and Haematology, University Hospital Zurich, Switzerland., Manz MG; Department of Medical Oncology and Haematology, University Hospital Zurich, Switzerland., Müller AMS; Department of Medical Oncology and Haematology, University Hospital Zurich, Switzerland., Widmer CC; Department of Medical Oncology and Haematology, University Hospital Zurich, Switzerland.
Publikováno v:
Swiss medical weekly [Swiss Med Wkly] 2022 Jun 20; Vol. 152, pp. w30186. Date of Electronic Publication: 2022 Jun 20 (Print Publication: 2022).
Autor:
Todisco G; Department of Molecular Medicine, University of Pavia, Pavia, Italy.; Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.; Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden., Creignou M; Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.; PO Hematology, Karolinska University Hospital, Stockholm, Sweden., Gallì A; Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Guglielmelli P; Center of Research and Innovation of Myeloproliferative Neoplasms, University of Florence, Azienda Ospedaliera Universitaria Careggi, Florence, Italy., Rumi E; Department of Molecular Medicine, University of Pavia, Pavia, Italy.; Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Roncador M; Department of Molecular Medicine, University of Pavia, Pavia, Italy.; Dana Farber Cancer Institute, Boston, MA, USA., Rizzo E; enGenome srl, Pavia, Italy., Nannya Y; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan., Pietra D; Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Elena C; Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Bono E; Department of Molecular Medicine, University of Pavia, Pavia, Italy.; Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Molteni E; Department of Molecular Medicine, University of Pavia, Pavia, Italy., Rosti V; Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy., Catricalá S; Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Sarchi M; Department of Molecular Medicine, University of Pavia, Pavia, Italy., Dimitriou M; Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden., Ungerstedt J; Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.; PO Hematology, Karolinska University Hospital, Stockholm, Sweden., Vannucchi AM; Center of Research and Innovation of Myeloproliferative Neoplasms, University of Florence, Azienda Ospedaliera Universitaria Careggi, Florence, Italy., Hellström-Lindberg E; Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.; PO Hematology, Karolinska University Hospital, Stockholm, Sweden., Ogawa S; Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.; Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto, Japan., Cazzola M; Department of Molecular Medicine, University of Pavia, Pavia, Italy.; Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Malcovati L; Department of Molecular Medicine, University of Pavia, Pavia, Italy. luca.malcovati@unipv.it.; Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. luca.malcovati@unipv.it.
Publikováno v:
Leukemia [Leukemia] 2021 Aug; Vol. 35 (8), pp. 2371-2381. Date of Electronic Publication: 2020 Dec 21.
Autor:
Kumar S; Dana Farber Cancer Institute, Boston, MA, USA.; Veterans Administration Healthcare System, Boston, MA, USA., Buon L; Dana Farber Cancer Institute, Boston, MA, USA., Talluri S; Dana Farber Cancer Institute, Boston, MA, USA.; Veterans Administration Healthcare System, Boston, MA, USA., Roncador M; Dana Farber Cancer Institute, Boston, MA, USA., Liao C; Dana Farber Cancer Institute, Boston, MA, USA.; Veterans Administration Healthcare System, Boston, MA, USA., Zhao J; Dana Farber Cancer Institute, Boston, MA, USA.; Veterans Administration Healthcare System, Boston, MA, USA., Shi J; Dana Farber Cancer Institute, Boston, MA, USA.; Veterans Administration Healthcare System, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Chakraborty C; Dana Farber Cancer Institute, Boston, MA, USA., Gonzalez G; Veterans Administration Healthcare System, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Tai YT; Dana Farber Cancer Institute, Boston, MA, USA., Prabhala R; Dana Farber Cancer Institute, Boston, MA, USA.; Veterans Administration Healthcare System, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Samur MK; Dana Farber Cancer Institute, Boston, MA, USA., Munshi NC; Dana Farber Cancer Institute, Boston, MA, USA.; Veterans Administration Healthcare System, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Shammas MA; Dana Farber Cancer Institute, Boston, MA, USA. Masood_Shammas@DFCI.Harvard.edu.; Veterans Administration Healthcare System, Boston, MA, USA. Masood_Shammas@DFCI.Harvard.edu.
Publikováno v:
Communications biology [Commun Biol] 2021 May 24; Vol. 4 (1), pp. 617. Date of Electronic Publication: 2021 May 24.
Autor:
Cabrini M; Istituto di Genetica Molecolare, CNR - Consiglio Nazionale delle Ricerche, Pavia 27100, Italy.; IFOM Foundation - The FIRC Institute of Molecular Oncology Foundation, Milan 20139, Italy., Roncador M; Istituto di Genetica Molecolare, CNR - Consiglio Nazionale delle Ricerche, Pavia 27100, Italy., Galbiati A; IFOM Foundation - The FIRC Institute of Molecular Oncology Foundation, Milan 20139, Italy., Cipolla L; Istituto di Genetica Molecolare, CNR - Consiglio Nazionale delle Ricerche, Pavia 27100, Italy., Maffia A; Istituto di Genetica Molecolare, CNR - Consiglio Nazionale delle Ricerche, Pavia 27100, Italy., Iannelli F; IFOM Foundation - The FIRC Institute of Molecular Oncology Foundation, Milan 20139, Italy., Sabbioneda S; Istituto di Genetica Molecolare, CNR - Consiglio Nazionale delle Ricerche, Pavia 27100, Italy., d'Adda di Fagagna F; Istituto di Genetica Molecolare, CNR - Consiglio Nazionale delle Ricerche, Pavia 27100, Italy fabrizio.dadda@ifom.eu sofia.francia@igm.cnr.it.; IFOM Foundation - The FIRC Institute of Molecular Oncology Foundation, Milan 20139, Italy., Francia S; Istituto di Genetica Molecolare, CNR - Consiglio Nazionale delle Ricerche, Pavia 27100, Italy fabrizio.dadda@ifom.eu sofia.francia@igm.cnr.it.; IFOM Foundation - The FIRC Institute of Molecular Oncology Foundation, Milan 20139, Italy.
Publikováno v:
Journal of cell science [J Cell Sci] 2021 Mar 22; Vol. 134 (6). Date of Electronic Publication: 2021 Mar 22.
Autor:
Ceruti S; Department of Critical Care, Clinica Luganese Moncucco, Lugano, Switzerland., Roncador M; Internal Medicine Service, Clinica Luganese Moncucco, Lugano, Switzerland.; Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland., Saporito A; Anesthesiology Division, Ospedale Regionale di Bellinzona e Valli, 6500 Bellinzona, Switzerland., Biggiogero M; Clinical Research Unit, Clinica Luganese Moncucco, Lugano, Switzerland., Glotta A; Department of Critical Care, Clinica Luganese Moncucco, Lugano, Switzerland., Maida PA; Clinical Research Unit, Clinica Luganese Moncucco, Lugano, Switzerland., Urso P; Radiotherapy Department, Clinica Luganese Moncucco, Lugano, Switzerland., Bona G; Internal Medicine Service, Clinica Luganese Moncucco, Lugano, Switzerland., Garzoni C; Internal Medicine Service, Clinica Luganese Moncucco, Lugano, Switzerland., Mauri R; Department of Critical Care, Clinica Luganese Moncucco, Lugano, Switzerland., Borgeat A; Anaesthesiology Division, Balgrist University Hospital, Zürich, Switzerland.
Publikováno v:
SN comprehensive clinical medicine [SN Compr Clin Med] 2021; Vol. 3 (12), pp. 2435-2442. Date of Electronic Publication: 2021 Jul 24.